Existing medicines and new uses
An overview of medicines repurposing, the challenges of generating evidence, and how actuarial analysis can support value‑based decision‑making.
An overview of medicines repurposing, the challenges of generating evidence, and how actuarial analysis can support value‑based decision‑making.
As the UK experiences more extreme heat events, the associated health risks are becoming more evident. Actuary Will Stobbs explores how rising temperatures interact with existing social and economic inequalities, drawing on GAD analysis to show where high heat exposure and deprivation overlap across England's neighbourhoods.
Not only has healthy life expectancy in the UK continued to decrease, the gap between HLE and life expectancy has widened, especially for women. This blog explores reasons why women may be living such a large proportion of their lives in poor health.
GAD's new climate and health group brings together expert analysis to help public sector clients understand climate-related health risks in long-term planning.
HLE and QALYs both measure quality of health - but they're built differently, used differently, and answer different policy questions. Find out more in this blog from GAD actuary Natasha Hill.
Recent Comments